Patients with untreated obstructive sleep apnea have been shown to have numerous cognitive disturbances, which can lead to poor work performance, work errors, and poor quality of life.
Short sleep duration is associated with daytime sleepiness, while obstructive sleep apnea is associated with obesity, hypertension, and dyslipidemia.
In addition to known predictors of apnea, diabetes-related foot disease, insulin treatment up risk.
Odds of sleep apnea increase with increase in nitrogen dioxide exposure, PM2.5 exposure.
Among OSA patients, risk for developing gout is highest 1 to 2 years after the index date.
The comorbid presence of central apnea has been identified by multiple researchers as predictive of SUDEP.
Monitoring mandibular movement reflects efficacy of oral appliance therapy in obstructive sleep apnea.
Continuous positive airway pressure for obstructive sleep apnea in patients with type 2 diabetes offered no improvement in visual acuity compared with usual care alone.
Poor control of asthma and obstructive sleep apnea can feed off one another, according to Michelle Zeidler, MD, pulmonologist at the University of California, Los Angeles, and director of the UCLA Sleep Fellowship Program.
Findings based on a portable monitor and use of a semi-automatic treatment algorithm
